ALK inhibitor crizotinib combined with intrathecal methotrexate treatment for non-small cell lung cancer with leptomeningeal carcinomatosis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

ALK inhibitor crizotinib combined with intrathecal methotrexate treatment for non-small cell lung cancer with leptomeningeal carcinomatosis

Published:2012-05 Issue:2 Volume:76 Page:253-254
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Ahn Hee Kyung,Han Boram,Lee Su Jin,Lim Taekyu,Sun Jong-Mu,Ahn Jin Seok,Ahn Myung-Ju,Park Keunchil

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference5 articles.

1. Carcinoma meningitis secondary to non-small cell lung cancer: combined modality therapy;Chamberlain;Arch Neurol,1998

2. Prognostic factors of leptomeningeal carcinomatosis in patients with non-small cell lung cancer;Lee;J Thorac Oncol,2011

3. CSF concentration of the anaplastic lymphoma kinase inhibitor crizotinib;Costa;J Clin Oncol,2011

4. Rapid and dramatic radiographic and clinical response to an ALK inhibitor (crizotinib, PF02341066) in an ALK translocation-positive patient with non-small cell lung cancer;Ou;J Thorac Oncol,2010

5. Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer;Kwak;N Engl J Med,2010

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Research Progress on the Mechanism of Occurrence and Treatment of Leptomeningeal Metastasis of Malignant Tumors;Advances in Clinical Medicine;2024

2. Emerging therapeutics and evolving assessment criteria for intracranial metastases in patients with oncogene-driven non-small-cell lung cancer;Nature Reviews Clinical Oncology;2023-08-17

3. Recent advances in electrochemical sensors and biosensors for monitoring drugs and metabolites in pharmaceutical and biological samples;ADMET and DMPK;2023-05-01

4. ALK TKI therapy in patients with ALK-positive non-small cell lung cancer and brain metastases: A review of the literature and local experiences;Critical Reviews in Oncology/Hematology;2022-12

5. Leptomeningeal Metastasis from Non–Small Cell Lung Cancer and Current Landscape of Treatments;Clinical Cancer Research;2022-08-16

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3